Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical Registry.

Pratt J, Jeffers D, King EC, Kappelman MD, Collins J, Margolis P, Baron H, Bass JA, Bassett MD, Beasley GL, Benkov KJ, Bornstein JA, Cabrera JM, Crandall W, Dancel LD, Garin-Laflam MP, Grunow JE, Hirsch BZ, Hoffenberg E, Israel E, Jester TW, Kiparissi F, Lakhole A, Lapsia SP, Minar P, Navarro FA, Neef H, Park KT, Pashankar DS, Patel AS, Pineiro VM, Samson CM, Sandberg KC, Steiner SJ, Strople JA, Sudel B, Sullivan JS, Suskind DL, Uppal V, Wali PD.

EGEMS (Wash DC). 2019 Sep 30;7(1):51. doi: 10.5334/egems.262.

2.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.

Zaunders J, Dyer WB, Churchill M, Munier CML, Cunningham PH, Suzuki K, McBride K, Hey-Nguyen W, Koelsch K, Wang B, Hiener B, Palmer S, Gorry PR, Bailey M, Xu Y, Danta M, Seddiki N, Cooper DA, Saksena NK, Sullivan JS, Riminton S, Learmont J, Kelleher AD.

J Virus Erad. 2019 Apr 1;5(2):73-83.

3.

Nutrition: Prevention and management of nutritional failure in Cystic Fibrosis.

Sullivan JS, Mascarenhas MR.

J Cyst Fibros. 2017 Nov;16 Suppl 2:S87-S93. doi: 10.1016/j.jcf.2017.07.010. Review.

4.

Source-space EEG neurofeedback links subjective experience with brain activity during effortless awareness meditation.

van Lutterveld R, Houlihan SD, Pal P, Sacchet MD, McFarlane-Blake C, Patel PR, Sullivan JS, Ossadtchi A, Druker S, Bauer C, Brewer JA.

Neuroimage. 2017 May 1;151:117-127. doi: 10.1016/j.neuroimage.2016.02.047. Epub 2016 Feb 26.

5.

pH dependence of cyanide and imidazole binding to the heme domains of Sinorhizobium meliloti and Bradyrhizobium japonicum FixL.

Bidwai AK, Ahrendt AJ, Sullivan JS, Vitello LB, Erman JE.

J Inorg Biochem. 2015 Dec;153:88-102. doi: 10.1016/j.jinorgbio.2015.10.003. Epub 2015 Oct 22.

6.

Non-operative management of fingertip injuries with an intravenous dressing.

Ha NB, Chang AC, Sullivan JS, Leonello DT.

J Wound Care. 2015 Jun;24(6):276, 278-9. doi: 10.12968/jowc.2015.24.6.276.

PMID:
26075376
7.

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration.

Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, Sullivan JS, Zhao Z, Meiselman HJ, Wendy RB, Soto J, Abel ED, Makshanoff J, Zuniga E, De Vivo DC, Zlokovic BV.

Nat Neurosci. 2015 Apr;18(4):521-530. doi: 10.1038/nn.3966. Epub 2015 Mar 2.

8.

Protective efficacy of a Plasmodium vivax circumsporozoite protein-based vaccine in Aotus nancymaae is associated with antibodies to the repeat region.

Yadava A, Hall CE, Sullivan JS, Nace D, Williams T, Collins WE, Ockenhouse CF, Barnwell JW.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3268. doi: 10.1371/journal.pntd.0003268. eCollection 2014 Oct.

9.

Development, manufacturing and characterization of a highly purified, liquid immunoglobulin g preparation from human plasma.

Laursen IA, Blou L, Sullivan JS, Bang P, Balstrup F, Houen G.

Transfus Med Hemother. 2014 Jun;41(3):205-12. doi: 10.1159/000357982. Epub 2014 Apr 14.

10.

ROHHADNET syndrome presenting as major behavioral changes in a 5-year-old obese girl.

Sethi K, Lee YH, Daugherty LE, Hinkle A, Johnson MD, Katzman PJ, Sullivan JS.

Pediatrics. 2014 Aug;134(2):e586-9. doi: 10.1542/peds.2013-2582. Epub 2014 Jul 21.

PMID:
25049346
11.

Oral fructose absorption in obese children with non-alcoholic fatty liver disease.

Sullivan JS, Le MT, Pan Z, Rivard C, Love-Osborne K, Robbins K, Johnson RJ, Sokol RJ, Sundaram SS.

Pediatr Obes. 2015 Jun;10(3):188-95. doi: 10.1111/ijpo.238. Epub 2014 Jun 24.

12.

A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.

Macintyre CR, Ridda I, Gao Z, Moa AM, McIntyre PB, Sullivan JS, Jones TR, Hayen A, Lindley RI.

PLoS One. 2014 Apr 23;9(4):e94578. doi: 10.1371/journal.pone.0094578. eCollection 2014.

13.

Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus.

Yuan FF, Velickovic Z, Ashton LJ, Dyer WB, Geczy AF, Dunckley H, Lynch GW, Sullivan JS.

Virol Sin. 2014 Apr;29(2):128-30. doi: 10.1007/s12250-014-3398-x. No abstract available.

PMID:
24643938
14.

Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice.

Winkler EA, Sengillo JD, Sagare AP, Zhao Z, Ma Q, Zuniga E, Wang Y, Zhong Z, Sullivan JS, Griffin JH, Cleveland DW, Zlokovic BV.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):E1035-42. doi: 10.1073/pnas.1401595111. Epub 2014 Mar 3.

15.

Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

Sundaram SS, Sokol RJ, Capocelli KE, Pan Z, Sullivan JS, Robbins K, Halbower AC.

J Pediatr. 2014 Apr;164(4):699-706.e1. doi: 10.1016/j.jpeds.2013.10.072. Epub 2013 Dec 7.

16.

Symptom response following acute bouts of exercise in concussed and non-concussed individuals - a systematic narrative review.

Balasundaram AP, Sullivan JS, Schneiders AG, Athens J.

Phys Ther Sport. 2013 Nov;14(4):253-8. doi: 10.1016/j.ptsp.2013.06.002. Epub 2013 Jul 10. Review.

PMID:
23849807
17.

Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease.

Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV.

Brain Pathol. 2013 May;23(3):303-10. doi: 10.1111/bpa.12004. Epub 2012 Nov 28.

18.

Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis.

Winkler EA, Sengillo JD, Sullivan JS, Henkel JS, Appel SH, Zlokovic BV.

Acta Neuropathol. 2013 Jan;125(1):111-20. doi: 10.1007/s00401-012-1039-8. Epub 2012 Sep 1.

19.

Schistosoma mansoni infection impairs antimalaria treatment and immune responses of rhesus macaques infected with mosquito-borne Plasmodium coatneyi.

Semenya AA, Sullivan JS, Barnwell JW, Secor WE.

Infect Immun. 2012 Nov;80(11):3821-7. doi: 10.1128/IAI.00590-12. Epub 2012 Aug 20.

20.

Gastroesophageal reflux.

Sullivan JS, Sundaram SS.

Pediatr Rev. 2012 Jun;33(6):243-53; quiz 254. doi: 10.1542/pir.33-6-243. Review. No abstract available.

PMID:
22659255
21.

Mosquito infection studies with Aotus monkeys and humans infected with the Chesson strain of Plasmodiun vivax.

Collins WE, Sullivan JS, Jeffery GM, Nace D, Williams T, Galland GG, Williams A, Barnwell JW.

Am J Trop Med Hyg. 2012 Mar;86(3):398-402. doi: 10.4269/ajtmh.2012.11-0264.

22.

Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation.

Sullivan JS, Sundaram SS, Pan Z, Sokol RJ.

Liver Transpl. 2012 Jan;18(1):120-8. doi: 10.1002/lt.22444.

23.

Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans.

Lynch GW, Selleck P, Church WB, Sullivan JS.

Immunol Cell Biol. 2012 Feb;90(2):149-58. doi: 10.1038/icb.2011.38. Epub 2011 Jun 7. Review.

PMID:
21647170
24.

Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae merozoite surface protein 1-p19 antibodies in human malaria patients and experimentally infected nonhuman primates.

Muerhoff AS, Birkenmeyer LG, Coffey R, Dille BJ, Barnwell JW, Collins WE, Sullivan JS, Dawson GJ, Desai SM.

Clin Vaccine Immunol. 2010 Oct;17(10):1631-8. doi: 10.1128/CVI.00196-10. Epub 2010 Aug 11.

25.

Heterosubtypic anti-avian H5N1 influenza antibodies in intravenous immunoglobulins from globally separate populations protect against H5N1 infection in cell culture.

Sullivan JS, Selleck PW, Downton T, Boehm I, Axell AM, Ayob Y, Kapitza NM, Dyer W, Fitzgerald A, Walsh B, Lynch GW.

J Mol Genet Med. 2009 Dec 23;3(2):217-24.

26.

Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza.

Lynch GW, Selleck P, Sullivan JS.

J Mol Genet Med. 2009 Dec 15;3(2):205-9.

27.

High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model.

Dutta S, Sullivan JS, Grady KK, Haynes JD, Komisar J, Batchelor AH, Soisson L, Diggs CL, Heppner DG, Lanar DE, Collins WE, Barnwell JW.

PLoS One. 2009 Dec 3;4(12):e8138. doi: 10.1371/journal.pone.0008138.

28.

Infection of mosquitoes with Plasmodium falciparum by feeding on humans and on Aotus monkeys.

Collins WE, Jeffery GM, Sullivan JS, Nace D, Williams T, Galland GG, Williams A, Barnwell JW.

Am J Trop Med Hyg. 2009 Sep;81(3):529-33.

PMID:
19706927
29.

HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.

Xu W, Santini PA, Sullivan JS, He B, Shan M, Ball SC, Dyer WB, Ketas TJ, Chadburn A, Cohen-Gould L, Knowles DM, Chiu A, Sanders RW, Chen K, Cerutti A.

Nat Immunol. 2009 Sep;10(9):1008-17. doi: 10.1038/ni.1753. Epub 2009 Aug 2.

30.

A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1.

Wong SK, Connole M, Sullivan JS, Choe H, Carville A, Farzan M.

J Virol. 2009 Sep;83(17):8771-80. doi: 10.1128/JVI.00112-09. Epub 2009 Jun 24.

31.

Plasmodium fieldi: observations on the Hackeri and ABI strains in Macaca mulatta monkeys and mosquitoes.

Collins WE, Sullivan JS, Warren M, Galland GG, Williams A, Barnwell JW.

Am J Trop Med Hyg. 2009 May;80(5):739-44.

PMID:
19407117
32.

The Santa Lucia strain of Plasmodium falciparum in Aotus monkeys.

Collins WE, Sullivan JS, Williams A, Galland GG, Nace D, Williams T, Barnwell JW.

Am J Trop Med Hyg. 2009 Apr;80(4):536-40.

PMID:
19346371
33.

Studies on the Salvador I strain of Plasmodium vivax in non-human primates and anopheline mosquitoes.

Collins WE, Sullivan JS, Strobert E, Galland GG, Williams A, Nace D, Williams T, Barnwell JW.

Am J Trop Med Hyg. 2009 Feb;80(2):228-35.

PMID:
19190218
34.

Plasmodium inui shortii: studies in old world and new world monkeys.

Collins WE, Warren M, Sullivan JS, Barnwell JW.

Am J Trop Med Hyg. 2009 Jan;80(1):160-4.

PMID:
19141855
35.

The Chesson strain of plasmodium vivax in humans and different species of Aotus monkeys.

Collins WE, Sullivan JS, Jeffery GM, Williams A, Galland GG, Nace D, Williams T, Barnwell JW.

Am J Trop Med Hyg. 2009 Jan;80(1):152-9.

PMID:
19141854
36.

Immunological responses to pneumococcal vaccine in frail older people.

Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, McIntyre PB.

Vaccine. 2009 Mar 4;27(10):1628-36. doi: 10.1016/j.vaccine.2008.11.098. Epub 2008 Dec 17. Erratum in: Vaccine. 2009 Nov 5;27(47):6649.

PMID:
19100304
37.

Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.

Dyer WB, Zaunders JJ, Yuan FF, Wang B, Learmont JC, Geczy AF, Saksena NK, McPhee DA, Gorry PR, Sullivan JS.

Retrovirology. 2008 Dec 11;5:112. doi: 10.1186/1742-4690-5-112.

38.

Transmission of different strains of Plasmodium cynomolgi to Aotus nancymaae monkeys and relapse.

Collins WE, Sullivan JS, Nace D, Williams T, Williams A, Barnwell JW.

J Parasitol. 2009 Apr;95(2):349-52. doi: 10.1645/GE-1797.1.

PMID:
18788885
39.

Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responses.

Lyon JA, Angov E, Fay MP, Sullivan JS, Girourd AS, Robinson SJ, Bergmann-Leitner ES, Duncan EH, Darko CA, Collins WE, Long CA, Barnwell JW.

PLoS One. 2008 Jul 30;3(7):e2830. doi: 10.1371/journal.pone.0002830.

40.

Observations on the sporozoite transmission of Plasmodium vivax to monkeys.

Collins WE, Sullivan JS, Nace D, Williams T, Williams A, Barnwell JW.

J Parasitol. 2008 Feb;94(1):287-8. doi: 10.1645/GE-1283.1.

PMID:
18372652
41.

Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection.

Yuan FF, Marks K, Wong M, Watson S, de Leon E, McIntyre PB, Sullivan JS.

Immunol Cell Biol. 2008 Mar-Apr;86(3):268-70. doi: 10.1038/sj.icb.7100155. Epub 2008 Jan 8.

PMID:
18180796
42.

Isolates of Plasmodium inui adapted to Macaca mulatta monkeys and laboratory-reared anopheline mosquitoes for experimental study.

Collins WE, Sullivan JS, Galland GG, Nace D, Williams A, Williams T, Barnwell JW.

J Parasitol. 2007 Oct;93(5):1061-9. doi: 10.1645/GE-1035R.1.

PMID:
18163340
43.

Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo.

Gorry PR, Churchill M, Learmont J, Cherry C, Dyer WB, Wesselingh SL, Sullivan JS.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):390-4.

PMID:
17993857
44.

High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus.

Yuan FF, Boehm I, Chan PK, Marks K, Tang JW, Hui DS, Sung JJ, Dyer WB, Geczy AF, Sullivan JS.

Clin Vaccine Immunol. 2007 Dec;14(12):1644-5. Epub 2007 Oct 3.

45.

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, Learmont J, Sullivan JS, Roche M, Zaunders JJ, Gabuzda D, Crowe SM, Mills J, Lewin SR, Brew BJ, Cunningham AL, Churchill MJ.

Retrovirology. 2007 Sep 23;4:66.

46.

Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys.

Collins WE, Sullivan JS, Hall P, Ruebush TK 2nd, Williams A, Grady KK, Bounngaseng A, Nace D, Williams T, Huber C, Galland GG, Barnwell JW, Sullivan JJ.

Am J Trop Med Hyg. 2007 Aug;77(2):261-5.

PMID:
17690397
47.

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.

Gray L, Churchill MJ, Sterjovski J, Witlox K, Learmont JC, Sullivan JS, Wesselingh SL, Gabuzda D, Cunningham AL, McPhee DA, Gorry PR.

Virol J. 2007 Jul 16;4:75.

48.

Studies on sporozoite-induced and chronic infections with Plasmodium fragile in Macaca mulatta and New World monkeys.

Collins WE, Warren M, Sullivan JS, Galland GG, Strobert E, Nace D, Williams A, Williams T, Barnwell JW.

J Parasitol. 2006 Oct;92(5):1019-26.

PMID:
17152944
49.

Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples.

Dyer WB, Pett SL, Sullivan JS, Emery S, Cooper DA, Kelleher AD, Lloyd A, Lewin SR.

Clin Vaccine Immunol. 2007 Jan;14(1):52-9. Epub 2006 Oct 18.

50.

CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells.

Zaunders JJ, Dyer WB, Munier ML, Ip S, Liu J, Amyes E, Rawlinson W, De Rose R, Kent SJ, Sullivan JS, Cooper DA, Kelleher AD.

J Virol. 2006 Oct;80(20):10151-61.

Supplemental Content

Loading ...
Support Center